张华敏;刘思鸿;高宏杰;贡磊磊;

• 1:中国中医科学院中医药信息研究所
• 2:首都医科大学附属北京妇产医院药事部

摘要(Abstract)：

复方中药是辨证审因决定治法,选择合适的药物药量,按照组成原则妥善配伍而成的一组药物。现代药理研究结果表明,复方中药具有"多成分、多靶点和多途径"协同作用的特点,使其研究更加难以展开。随着医学科学和生命科学步入后基因组时代,以系统生物学、多项药理学生物信息学相结合的网络药理学被广泛应用于复方中药的现代化研究。网络药理学强调网络靶标的研究模式,从整体上探索药物与疾病的相关性,这与复方中药的整体性和系统性不谋而合。本文将就网络药理学在复方中药中的研究方法、应用和存在的问题进行概述,以期为复方中药的网络药理学研究提供参考。

关键词(KeyWords)： 复方中药;网络药理学;研究进展

Abstract:

Keywords:

基金项目(Foundation): 国家自然基金面上项目(No.81873199)

作者(Authors): 张华敏;刘思鸿;高宏杰;贡磊磊;

DOI: 10.14009/j.issn.1672-2124.2019.10.035

参考文献(References)：

• [1] Cyranoski D.Why Chinese medicine is heading for clinics around the world[J].Nature,2018,561(7724):448-450.
• [2] 王勇,李春,仇琪,等.中药复方多成分多靶点协同增效药理药效评价体系[J].中国科学:生命科学,2016,46(8):1029-1032.
• [3] Hao da C,Xiao PG.Network pharmacology:a Rosetta Stone for tradi-tional Chinese medicine[J].Drug Dev Res,2014,75(5):299-312.
• [4] Li S,Zhang ZQ,Wu LJ,et al.Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network[J].IET Syst Biol,2007,1(1):51-60.
• [5] Hopkins AL.Network pharmacology[J].Nat Biotechnol,2007,25(10):1110-1111.
• [6] 许海玉,杨洪军.整合药理学:中药现代研究新模式[J].中国中药杂志,2014,39(3):357-362.
• [7] Amberger JS,Bocchini CA,Schiettecatte F,et al.OMIM.org:Online Mendelian Inheritance in Man (OMIM?),an online catalog of human genes and genetic disorders[J].Nucleic Acids Res,2015,43(Database issue):D789-D798.
• [8] Oughtred R,Stark C,Breitkreutz B,et al.The BioGRID interaction database:2019 update[J].Nucleic Acids Res,2019.doi:10.1093/nar/gky1079.
• [9] Blohm P,Frishman G,Smialowski P,et al.Negatome 2.0:a database of non-interacting proteins derived by literature mining,manual annotation and protein structure analysis[J].Nucleic Acids Res,2014,42(Database issue):D396-D400.
• [10] Keshava Prasad TS,Goel R,Kandasamy K,et al.Human Protein Reference Database—2009 update[J].Nucleic Acids Res,2009,37(Database issue):D767-D772.
• [11] Gene Ontology Consortium.Gene Ontology Consortium:going forward[J].Nucleic Acids Res,2015,43(Database issue):D1049-D1056.
• [12] Dennis G Jr,Sherman BT,Hosack DA,et al.DAVID:Database for Annotation,visualization,and Integrated Discovery[J].Genome Biol,2003,4(9):R60.1-R60.11.
• [13] The UniProt Consortium.UniProt:the universal protein knowledgebase[J].Nucleic Acids Res,2017,45(D1):D158-D169.
• [14] Kanehisa M,Goto S.KEGG:kyoto encyclopedia of genes and genomes[J].Nucleic Acids Res,2000,28(1):27-30.
• [15] Fabregat A,Jupe S,Matthews L,et al.The Reactome Pathway Knowledgebase[J].Nucleic Acids Res,2018,46(D1):D649-D655.
• [16] Thorn CF,Klein TE,Altman RB.PharmGKB:the Pharmaco-genomics Knowledge Base[J].Methods Mol Biol,2013,1015:311-320.
• [17] Li YH,Yu CY,Li XX,et al.Therapeutic target database update 2018:enriched resource for facilitating bench-to-clinic research of targeted therapeutics[J].Nucleic Acids Res,2018,46(D1):D1121-D1127.
• [18] Wishart DS,Feunang YD,Guo AC,et al.DrugBank 5.0:a major update to the DrugBank database for 2018[J].Nucleic Acids Res,2017,46(D1):D1074-D1082.
• [19] Kuhn M,von Mering C,Campillos M,et al.STITCH:interaction networks of chemicals and proteins[J].Nucleic Acids Res,2008,36(Database issue):D684-D688.
• [20] Kim S,Chen J,Cheng T,et al.PubChem 2019 update:improved access to chemical data[J].Nucleic Acids Res,2019,47(D1):D1102-D1109.
• [21] Gaulton A,Hersey A,Nowotka M,et al.The ChEMBL database in 2017[J].Nucleic Acids Res,2017,45(D1):D945-D954.
• [22] Xue R,Fang Z,Zhang M,et al.TCMID:Traditional Chinese Medicine integrative database for herb molecular mechanism analysis[J].Nucleic Acids Res,2013,41(Database issue):D1089-D1095.
• [23] Chen X,Liu MX,Yan GY.Drug-target interaction prediction by random walk on the heterogeneous network[J].Mol BioSyst,2012,8(7):1970-1978.
• [24] Vanunu O,Magger O,Ruppin E,et al.Associating genes and protein complexes with disease via network propagation[J].PLoS Comput Biol,2010,6(1):e1000641.
• [25] Li S,Zhang B.Traditional Chinese medicine network pharmacology:theory,methodology and application[J].Chin J Nat Med,2013,11(2):110-120.
• [26] Lopes CT,Franz M,Kazi F,et al.Cytoscape Web:an interactive web-based network browser[J].Bioinformatics,2010,26(18):2347-2348.
• [27] Xu HY,Zhang YQ,Liu ZM,et al.ETCM:an encyclopaedia of traditional Chinese medicine[J].Nucleic Acids Res,2019,47(D1):D976-D982.
• [28] 张彦琼,李梢.网络药理学与中医药现代研究的若干进展[J].中国药理学与毒理学杂志,2015,29(6):883-892.
• [29] Haiyu X,Yang S,Yanqiong Z,et al.Identification of key active constituents of Buchang Naoxintong capsules with therapeutic effects against ischemic stroke by using an integrative pharmacology-based approach[J].Mol BioSyst,2015,12(1):233-245.
• [30] 王韵.茵陈蒿汤网络药理学与药效物质基础研究[D].上海:第二军医大学,2017.
• [31] Jiang X,Lv B,Li P,et al.Bioactivity-integrated UPLC/Q-TOF-MS of Danhong injection to identify NF-κB inhibitors and anti-inflam-matory targets based on endothelial cell culture and network pharmacology[J].J Ethnopharmacol,2015,174:270-276.
• [32] Wu L,Wang Y,Li Z,et al.Identifying roles of “Jun-Chen-Zuo-Shi” component herbs of QiShenYiQi formula in treating acute myocardial ischemia by network pharmacology[J].Chine Med,2014,9(1):24.
• [33] 金燕萍.基于数据挖掘和网络药理学的清热类中成药组方规律研究[D].北京:北京中医药大学,2016.
• [34] 严瑶琦,孙静,张莉,等.基于数据挖掘和网络药理学的痛风湿热蕴结证用药规律和作用机制分析[J].中国中药杂志,2018,43(13):2824-2830.
• [35] Liang X,Li H,Li S.A novel network pharmacology approach to analyse traditional herbal formulae:the Liu-Wei-Di-Huang pill as a case study[J].Mol BioSyst,2014,10(5):1014-1022.
• [36] Li H,Zhao L,Zhang B,et al.A network pharmacology approach to determine active compounds and action mechanisms of ge-gen-qin-lian decoction for treatment of type 2 diabetes[J].Evid Based Complement Alternat Med,2014,2014:495840.